These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30239023)

  • 1. Environmental Surveillance System Characteristics and Impacts on Confidence About No Undetected Serotype 1 Wild Poliovirus Circulation.
    Kalkowska DA; Duintjer Tebbens RJ; Thompson KM
    Risk Anal; 2019 Feb; 39(2):414-425. PubMed ID: 30239023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and Afghanistan.
    Kalkowska DA; Duintjer Tebbens RJ; Pallansch MA; Thompson KM
    Risk Anal; 2019 Feb; 39(2):402-413. PubMed ID: 30296340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan - 2011-2013.
    Cowger TL; Burns CC; Sharif S; Gary HE; Iber J; Henderson E; Malik F; Zahoor Zaidi SS; Shaukat S; Rehman L; Pallansch MA; Orenstein WA
    PLoS One; 2017; 12(7):e0180608. PubMed ID: 28742803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population sensitivity of acute flaccid paralysis and environmental surveillance for serotype 1 poliovirus in Pakistan: an observational study.
    O'Reilly KM; Verity R; Durry E; Asghar H; Sharif S; Zaidi SZ; Wadood MZM; Diop OM; Okayasu H; Safdar RM; Grassly NC
    BMC Infect Dis; 2018 Apr; 18(1):176. PubMed ID: 29653509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights From Modeling Preventive Supplemental Immunization Activities as a Strategy to Eliminate Wild Poliovirus Transmission in Pakistan and Afghanistan.
    Kalkowska DA; Thompson KM
    Risk Anal; 2021 Feb; 41(2):266-272. PubMed ID: 32144841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Borno and Yobe in Northeast Nigeria.
    Kalkowska DA; Thompson KM
    Risk Anal; 2021 Feb; 41(2):303-311. PubMed ID: 32348634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling undetected live type 1 wild poliovirus circulation after apparent interruption of transmission: Pakistan and Afghanistan.
    Kalkowska DA; Badizadegan K; Thompson KM
    Risk Anal; 2023 Apr; 43(4):677-685. PubMed ID: 35739067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental Surveillance Complements Case-Based Surveillance of Acute Flaccid Paralysis in Polio Endgame Strategy 2019-2023.
    Chen P; Liu Y; Wang H; Liu G; Lin X; Zhang W; Ji F; Xu Q; Tao Z; Xu A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32444474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental surveillance for polioviruses in the Global Polio Eradication Initiative.
    Asghar H; Diop OM; Weldegebriel G; Malik F; Shetty S; El Bassioni L; Akande AO; Al Maamoun E; Zaidi S; Adeniji AJ; Burns CC; Deshpande J; Oberste MS; Lowther SA
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S294-303. PubMed ID: 25316848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan.
    Duintjer Tebbens RJ; Thompson KM
    Risk Anal; 2019 Feb; 39(2):389-401. PubMed ID: 30239026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the sensitivity of the polio environmental surveillance system.
    Kroiss SJ; Ahmadzai M; Ahmed J; Alam MM; Chabot-Couture G; Famulare M; Mahamud A; McCarthy KA; Mercer LD; Muhammad S; Safdar RM; Sharif S; Shaukat S; Shukla H; Lyons H
    PLoS One; 2018; 13(12):e0208336. PubMed ID: 30592720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Epidemiology Reveals 3 Chronic Reservoir Areas With Recurrent Population Mobility Challenging Poliovirus Eradication in Pakistan.
    Akhtar R; Mahmood N; Alam MM; Naeem M; Zaidi SSZ; Sharif S; Khattak Z; Arshad Y; Khurshid A; Mujtaba G; Rehman L; Angez M; Shaukat S; Mushtaq N; Umair M; Ikram A; Salman M
    Clin Infect Dis; 2020 Oct; 71(7):e58-e67. PubMed ID: 31665247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance To Track Progress Toward Poliomyelitis Eradication - Worldwide, 2021-2022.
    Stehling-Ariza T; Wilkinson AL; Diop OM; Jorba J; Asghar H; Avagnan T; Grabovac V; Johnson T; Joshi S; Kfutwah AKW; Sangal L; Sharif S; Wahdan A; Tallis GF; Kovacs SD
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(23):613-620. PubMed ID: 37289657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Poliovirus Surveillance and Immunization Campaign Quality Monitoring Costs for Pakistan and Afghanistan for 2019-2023.
    Kalkowska DA; Pallansch MA; Cochi SL; Thompson KM
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab264. PubMed ID: 34295942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and short-term projections for serotype-1 poliomyelitis incidence in Pakistan: A spatiotemporal analysis.
    Molodecky NA; Blake IM; O'Reilly KM; Wadood MZ; Safdar RM; Wesolowski A; Buckee CO; Bandyopadhyay AS; Okayasu H; Grassly NC
    PLoS Med; 2017 Jun; 14(6):e1002323. PubMed ID: 28604777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successes and challenges of expansion of environmental poliovirus surveillance in the WHO South-East Asia Region.
    Garg A; Pattamadilok S; Bahl S
    WHO South East Asia J Public Health; 2018 Sep; 7(2):122-128. PubMed ID: 30136671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress Toward Poliomyelitis Eradication - Afghanistan, January 2016-June 2017.
    Martinez M; Shukla H; Nikulin J; Wadood MZ; Hadler S; Mbaeyi C; Tangermann R; Jorba J; Ehrhardt D
    MMWR Morb Mortal Wkly Rep; 2017 Aug; 66(32):854-858. PubMed ID: 28817551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.
    Molodecky NA; Jafari H; Safdar RM; Ahmed JA; Mahamud A; Bandyopadhyay AS; Shukla H; Quddus A; Zaffran M; Sutter RW; Grassly NC; Blake IM
    Vaccine; 2023 Apr; 41 Suppl 1():A93-A104. PubMed ID: 34629206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress Toward Poliomyelitis Eradication - Afghanistan, January 2017-May 2018.
    Martinez M; Shukla H; Ahmadzai M; Nikulin J; Wadood MZ; Ahmed J; Mbaeyi C; Jorba J; Ehrhardt D
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(30):833-837. PubMed ID: 30070983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020-2021.
    Faye M; Kébé O; Diop B; Ndiaye N; Dosseh A; Sam A; Diallo A; Dia H; Diallo JP; Dia N; Kiori DE; Diop OM; Sall AA; Faye O
    Emerg Infect Dis; 2022 Oct; 28(10):2027-2034. PubMed ID: 36148906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.